Fibrobiologics

IN THE PRESS

Press Releases

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

October 29, 2024

·

5 min read

Press Releases

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

October 28, 2024

·

1 min read

News

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

October 18, 2024

·

5 min read

Press Releases

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

October 17, 2024

·

4 min read

Business

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

October 11, 2024

·

1 min read

Business

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

September 30, 2024

·

3 min read

Press Releases

FibroBiologics Engages Southern Star Research as CRO in Australia

September 20, 2024

·

5 min read

News

FibroBiologics Announces Filing of Patent Application for Generation of Functional Hematopoietic Organoids using Fibroblast Cell-Based Technology

September 12, 2024

·

4 min read

Press Releases

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

September 12, 2024

·

4 min read

Press Releases

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

September 6, 2024

·

1 min read

JOBS